New Jersey A 3630: Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2024-02-12)

State: New Jersey · Session: 221 · Bill: A 3630

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Murphy, Carol A.

View New Jersey A 3630 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.